Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TERT promoter mutation subtypes and survival in stage I and II melanoma patients
Juan José Andrés Lencina, P. Sivaramakrishna Rachakonda, Zaida García‐Casado, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 5, pp. 1027-1036
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Telomeres and Telomere Length: A General Overview
Nalini Srinivas, P. Sivaramakrishna Rachakonda, Rajiv Kumar
Cancers (2020) Vol. 12, Iss. 3, pp. 558-558
Open Access | Times Cited: 236
TERT—Regulation and Roles in Cancer Formation
Marta Dratwa, Barbara Wysoczańska, Piotr Łacina, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 210
Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities
Roy Rabbie, Peter M. Ferguson, Christian Molina‐Aguilar, et al.
The Journal of Pathology (2018) Vol. 247, Iss. 5, pp. 539-551
Open Access | Times Cited: 183
Somatic genetic rescue in Mendelian haematopoietic diseases
Patrick Revy, Caroline Kannengiesser, Alain Fischer
Nature Reviews Genetics (2019) Vol. 20, Iss. 10, pp. 582-598
Closed Access | Times Cited: 92
TERT Promoter Mutations and Telomerase in Melanoma
Yuchen Guo, Yi Chen, Lianghui Zhang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 29
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies
Lucia Di Nardo, Cristina Pellegrini, Alessandro Di Stefani, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 5, pp. 932-941
Closed Access | Times Cited: 48
Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review
Semir Vranić, Nikola Šerman, Mislav Glibo, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 24
<i>TERT</i> promoter mutations in thyroid cancer
Michiko Matsuse, Norisato Mitsutake
Endocrine Journal (2023) Vol. 70, Iss. 11, pp. 1035-1049
Open Access | Times Cited: 14
The Solo Play of TERT Promoter Mutations
François Hafezi, Danielle Perez-Bercoff
Cells (2020) Vol. 9, Iss. 3, pp. 749-749
Open Access | Times Cited: 38
TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis
Sara Gandini, Ines Zanna, Simone De Angelis, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 160, pp. 103288-103288
Closed Access | Times Cited: 29
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations
Maria Lina Tornesello, Andrea Cerasuolo, Noemy Starita, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Songting Shou, Ayidana Maolan, Di Zhang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma
Lisa Gabler, Daniela Lötsch, Dominik Kirchhofer, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 33
Mechanistic basis of atypical TERT promoter mutations
Kerryn Elliott, Vinod Kumar Singh, Alan Bäckerholm, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
TERT promoter mutations in melanoma survival
Eduardo Nagore, P. Sivaramakrishna Rachakonda, Rajiv Kumar
Oncotarget (2019) Vol. 10, Iss. 16, pp. 1546-1548
Open Access | Times Cited: 28
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma
Maria Giovanna Maturo, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 23
TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients
Lídia Maria Rebolho Batista Arantes, Adriana Cruvinel‐Carloni, Ana Carolina de Carvalho, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 22
Occurrence, functionality and abundance of the TERT promoter mutations
Sivaramakrishna Rachakonda, Jörg D. Hoheisel, Rajiv Kumar
International Journal of Cancer (2021) Vol. 149, Iss. 11, pp. 1852-1862
Open Access | Times Cited: 19
TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis
Kiran Motaparthi, Jinah Kim, Aleodor A. Andea, et al.
Journal of Cutaneous Pathology (2020) Vol. 47, Iss. 8, pp. 710-719
Open Access | Times Cited: 20
Clinical, environmental and histological distribution ofBRAF,NRASandTERTpromoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients*
Esperanza Manrique‐Silva, S. Rachakonda, David Millán-Esteban, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 3, pp. 504-513
Open Access | Times Cited: 20
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients
Paola Del Bianco, Camilla Stagni, Silvia Giunco, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 946-946
Open Access | Times Cited: 19
Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
Yujiro Hayashi, Kazutoshi Fujita, George J. Netto, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 16
Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma
Alessandra Ventura, Cristina Pellegrini, Ludovica Cardelli, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1333-1333
Open Access | Times Cited: 19
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study
Alicia Barreiro, Juan José Andrés Lencina, Sebastián Podlipnik, et al.
European Journal of Cancer (2021) Vol. 145, pp. 29-37
Closed Access | Times Cited: 15
Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort
Gregory Chang, Eric M. Robinson, Jennifer Wiggins, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 10, pp. 2733-2743.e9
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top